![]() ![]() SFLG is registered with the Fundraising Regulator and complies with its practices. In May, SFLG sends a copy of its Annual Review describing the previous year’s activities and in October it sends a further newsletter informing donors of how their donations are being used. SFLG communicates twice a year with existing opted-in donors. The main means of introducing new donors and raising funds is through inserts in various press titles. Marketing In 2021, SFLG’s individual giving increased to £245,622 including Gift Aid. In total, over 20 articles were written in response to SFLG campaigns. advising that countries were cautious about declaring ‘elimination’ and ensuring that enough focus and resources remained in place to drive leprosy across the final mile.SFLG raised awareness of why people with leprosy might be especially vulnerable to Covid-19 and championed their right to receive vaccines in parity to their peers ensuring people with leprosy had equitable access to the Covid-19 vaccine when it was rolled out.In cases where beneficiaries are supported for a significant period, additional due diligence is undertaken if there is a change of circumstances that might impact the partner or in any case, every year.Ĭampaigning In 2021, SFLG campaigned on several issues affecting people with leprosy. The results of any due diligence do not last indefinitely. Where the proposed partner is well-known to the CIO and the relationship has been long-standing and well-established, the amount of due diligence undertaken is likely to be reduced. the nature of the relationship between the charity and the applicant.the geographical location in which the grant will be applied.the country of residence of the recipient.SFLG also adopts a risk-rated approach to due diligence. that funds are not knowingly used for money laundering, financing terrorism or bribery.that funds are applied in accordance with SFLG’s charitable purposes.Partner due diligence SFLG carried out due diligence on any potential partners to ensure: In 2021, SFLG worked in 13 countries worldwide, supporting 40 centres. It commends its achievements in 2021, thanks its benefactors who made its achievements possible and, invites their future support. Consequently, it has increased its fundraising activities and is involved in ever more work. It is passionate about seizing the moment to end leprosy for good. Inspired by the great examples from its past and invigorated by the unique opportunity to end leprosy completely in this generation, SFLG is in a phase of growth. The CIO has joined several global boards to strategise, co-ordinate and work together to break the transmission of leprosy and end leprosy for good. These boards include the Global Partnership for Zero Leprosy, the Leprosy Research Initiative, the Neglected Tropical Diseases NGO Network (NNN) and International Anti-leprosy Federation (ILEP.) Through these relationships, SFLG now has direct links with the World Health Organization and the United Nations. SFLG has engaged with this approach, responded to opportunities and in particular, has expanded its work beyond the care of leprosy patients, to include research, education, and Active Case-Finding. ![]() ![]() Since a cure was found for leprosy in the 1980s, Non-Government Organisations (NGOs) across the world have a shared vision to end leprosy for good. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |